Adrenomedullin protects against ischaemia-induced arrhythmias and injury in anaesthetised rats

Yee H. Looi, Cherry L. Wainwright, Kathleen A. Kane

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Adrenomedulin (AM) is a novel peptide which has pronounced effects on the cardiovascular system (Kltamura e! al., 1993). The precise role of AM during myocardlal ischaemia is, however, unknown. The aim of this study was to determine if AM has a cardioprotective effect dunng myoeardial ischaemia. Pentobarbitone-anaesthetised rats were subjected to ligation of the left main coronary artery for 30 min followed by 120 min of reperfusion. Hearts were stained with Evan's blue and triphcnyltetrazolium chloride at the end of experiments for area at risk and infarct size measurement respectively. Animals were administered an i.v. bolus dose of Ah4 (0.5 ntn~lkg and 1 nmollkg) or saline 5 min preocclusion. Both doses of AM significantly reduced the number of ventricular ectoplc beats that occurred during ischaemia from 1339*116 to 521*116 and 520574 respectively (WO.05) and the incidences of VF from 66% to 26% and 27% respectively (IQO.05). Infarct size was significantly reduced from 34*3% to l&2% of area at risk in both AM treatment groups (WO.05). Prior to occlusion, AM (1 nmol/kg) induced a significant decrease in MABP (851% decrease, P<O.OS). These results show that AM exerts cardioprotection against Ischaemia-induced arrhythmias and myocardial injury.
LanguageEnglish
PagesA39-A39
JournalJournal of Molecular and Cellular Cardiology
Volume34
Issue number6
DOIs
Publication statusPublished - Jun 2002

Fingerprint

Adrenomedullin
Cardiac Arrhythmias
Ischemia
Wounds and Injuries
Evans Blue
Pentobarbital
Cardiovascular System
Reperfusion
Ligation
Chlorides
Coronary Vessels
Peptides
Incidence

Keywords

  • Adrenomedulin
  • (AM)
  • ischaemia
  • arrhythmias

Cite this

Looi, Yee H. ; Wainwright, Cherry L. ; Kane, Kathleen A. / Adrenomedullin protects against ischaemia-induced arrhythmias and injury in anaesthetised rats. In: Journal of Molecular and Cellular Cardiology. 2002 ; Vol. 34, No. 6. pp. A39-A39.
@article{6ea7dcfe3b2a4466a51bb028203c8547,
title = "Adrenomedullin protects against ischaemia-induced arrhythmias and injury in anaesthetised rats",
abstract = "Adrenomedulin (AM) is a novel peptide which has pronounced effects on the cardiovascular system (Kltamura e! al., 1993). The precise role of AM during myocardlal ischaemia is, however, unknown. The aim of this study was to determine if AM has a cardioprotective effect dunng myoeardial ischaemia. Pentobarbitone-anaesthetised rats were subjected to ligation of the left main coronary artery for 30 min followed by 120 min of reperfusion. Hearts were stained with Evan's blue and triphcnyltetrazolium chloride at the end of experiments for area at risk and infarct size measurement respectively. Animals were administered an i.v. bolus dose of Ah4 (0.5 ntn~lkg and 1 nmollkg) or saline 5 min preocclusion. Both doses of AM significantly reduced the number of ventricular ectoplc beats that occurred during ischaemia from 1339*116 to 521*116 and 520574 respectively (WO.05) and the incidences of VF from 66{\%} to 26{\%} and 27{\%} respectively (IQO.05). Infarct size was significantly reduced from 34*3{\%} to l&2{\%} of area at risk in both AM treatment groups (WO.05). Prior to occlusion, AM (1 nmol/kg) induced a significant decrease in MABP (851{\%} decrease, P<O.OS). These results show that AM exerts cardioprotection against Ischaemia-induced arrhythmias and myocardial injury.",
keywords = "Adrenomedulin, (AM), ischaemia, arrhythmias",
author = "Looi, {Yee H.} and Wainwright, {Cherry L.} and Kane, {Kathleen A.}",
note = "Also published in the British Journal of Pharmacology (2002), 135 (Proceedings supplement).",
year = "2002",
month = "6",
doi = "10.1016/S0022-2828(02)90882-5",
language = "English",
volume = "34",
pages = "A39--A39",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
number = "6",

}

Adrenomedullin protects against ischaemia-induced arrhythmias and injury in anaesthetised rats. / Looi, Yee H.; Wainwright, Cherry L.; Kane, Kathleen A.

In: Journal of Molecular and Cellular Cardiology, Vol. 34, No. 6, 06.2002, p. A39-A39.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adrenomedullin protects against ischaemia-induced arrhythmias and injury in anaesthetised rats

AU - Looi, Yee H.

AU - Wainwright, Cherry L.

AU - Kane, Kathleen A.

N1 - Also published in the British Journal of Pharmacology (2002), 135 (Proceedings supplement).

PY - 2002/6

Y1 - 2002/6

N2 - Adrenomedulin (AM) is a novel peptide which has pronounced effects on the cardiovascular system (Kltamura e! al., 1993). The precise role of AM during myocardlal ischaemia is, however, unknown. The aim of this study was to determine if AM has a cardioprotective effect dunng myoeardial ischaemia. Pentobarbitone-anaesthetised rats were subjected to ligation of the left main coronary artery for 30 min followed by 120 min of reperfusion. Hearts were stained with Evan's blue and triphcnyltetrazolium chloride at the end of experiments for area at risk and infarct size measurement respectively. Animals were administered an i.v. bolus dose of Ah4 (0.5 ntn~lkg and 1 nmollkg) or saline 5 min preocclusion. Both doses of AM significantly reduced the number of ventricular ectoplc beats that occurred during ischaemia from 1339*116 to 521*116 and 520574 respectively (WO.05) and the incidences of VF from 66% to 26% and 27% respectively (IQO.05). Infarct size was significantly reduced from 34*3% to l&2% of area at risk in both AM treatment groups (WO.05). Prior to occlusion, AM (1 nmol/kg) induced a significant decrease in MABP (851% decrease, P<O.OS). These results show that AM exerts cardioprotection against Ischaemia-induced arrhythmias and myocardial injury.

AB - Adrenomedulin (AM) is a novel peptide which has pronounced effects on the cardiovascular system (Kltamura e! al., 1993). The precise role of AM during myocardlal ischaemia is, however, unknown. The aim of this study was to determine if AM has a cardioprotective effect dunng myoeardial ischaemia. Pentobarbitone-anaesthetised rats were subjected to ligation of the left main coronary artery for 30 min followed by 120 min of reperfusion. Hearts were stained with Evan's blue and triphcnyltetrazolium chloride at the end of experiments for area at risk and infarct size measurement respectively. Animals were administered an i.v. bolus dose of Ah4 (0.5 ntn~lkg and 1 nmollkg) or saline 5 min preocclusion. Both doses of AM significantly reduced the number of ventricular ectoplc beats that occurred during ischaemia from 1339*116 to 521*116 and 520574 respectively (WO.05) and the incidences of VF from 66% to 26% and 27% respectively (IQO.05). Infarct size was significantly reduced from 34*3% to l&2% of area at risk in both AM treatment groups (WO.05). Prior to occlusion, AM (1 nmol/kg) induced a significant decrease in MABP (851% decrease, P<O.OS). These results show that AM exerts cardioprotection against Ischaemia-induced arrhythmias and myocardial injury.

KW - Adrenomedulin

KW - (AM)

KW - ischaemia

KW - arrhythmias

UR - http://dx.doi.org/10.1016/S0022-2828(02)90882-5

U2 - 10.1016/S0022-2828(02)90882-5

DO - 10.1016/S0022-2828(02)90882-5

M3 - Article

VL - 34

SP - A39-A39

JO - Journal of Molecular and Cellular Cardiology

T2 - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 6

ER -